Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a minor system update and does not alter core study details, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe generic government funding notice at the top of the page was removed.SummaryDifference0.4%

- Check42 days agoChange DetectedScreenshots show only minor text and layout adjustments on the study page, with no changes to core content, eligibility, outcomes, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference2%

- Check78 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.0%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' control was removed.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.